NCT04683068View on ClinicalTrials.gov

Promoting Men's Adherence to BRCA1/2 Germline Genetic Testing

NACompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

January 10, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
BRCA1 MutationBRCA2 MutationPsychosocial Factors
Interventions
BEHAVIORAL

Message comparison

Message comparison

Trial Locations (1)

20141

European Institute of Onocolgy, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER

NCT04683068 - Promoting Men's Adherence to BRCA1/2 Germline Genetic Testing | Biotech Hunter | Biotech Hunter